You are browsing the archives of Transmeta.

VS.

Intel and Transmeta have now come to an agreement. The agreement calls for Intel to license Transmeta’s patents for $150M upfront and $20M a year for the next five years, and Intel can do nothing if Transmeta decides to license its LongRun tech to another company. No info on how the company plans to serve its two competitors.